Ovarian Serous Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-05-28
Clinical Trial Update: FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study [Phase 2]
A Phase 2 study (FUCHSia) evaluating fulvestrant for hormone-sensitive gynecologic cancers has completed, investigating its activity in uter…